The effects of dietary 1, 3-diacylglycerol-rich oil (DG oil) on glucose and lipid metabolism were investigated in comparison with triacylglycerol (TG) oil in female geneti cally obese Wistar fatty rats. The obese rats and their lean littermates (8wk old) were fed a synthetic diet containing 10% (w/w) DG or TG oil for 5 wk. The body weights, abdominal fat weights, and the plasma and liver TG concentrations were not significantly different due to dietary fat type in the obese and lean rats. The plasma glucose concentrations were sig nificantly elevated by dietary DG oil as compared to TG oil in the portal vein and inferior vena cava of obese and lean rats. The plasma free fatty acid concentrations were markedly elevated by dietary DG oil as compared to TG oil in the portal vein and inferior vena cava of both genotype rats, particularly in the obese rats. In the glucose tolerance test, the obese rats fed DG oil showed glucose intolerance, possibly due to the markedly elevated plasma free fatty acids. Thus, the effects of dietary DG oil on lipid-lowering effects and anti-obesity were not observed in either genotype in the present study. Moreover, it is remarkable that glucose intolerance was induced by dietary DG oil in the genetically obese rats.
Several studies on the lipid lowering effects of 1, 3-di acylglycerol-rich oil (DG oil) have been reported from the research laboratories of a company that produces DG oil. In these studies (1) (2) (3) (4) , DG oil suppressed the ac cumulation of fat as compared to triacylglycerol (TG) oil in humans and rats, and possibly reduced the risk of diseases associated with visceral fat obesity. Oral intu bation of an emulsion containing DG oil reduced the serum TG levels as compared to TG oil infusion in rats and markedly elevated the portal vein free fatty acid lev els (1) . However, the energy values and apparent di gestibility of the DG and TG oils were similar (5) . Thus, they suggested that the reduction of fat accumulation by dietary DG oil might be ascribed to a different ab sorption mechanism from that for TG oil.
Increased plasma free fatty acid concentrations have commonly been associated with impaired insulin-medi ated glucose uptake and with many insulin-resistant states (6, 7) . Fatty acid-rich medium reduced insulin re ceptor tyrosin kinase activity in rat hepatoma cells (8) . Dresner et al. (9) concluded that increased concentra tions of plasma free fatty acids induce insulin resistance in humans through the inhibition of glucose transport activity. Therefore, extensive physiological and nutri tional studies on DG oil are required before the syn thetic oil can be recommended for use in daily diets.
A synthetic oil product containing a high level of DG oil (55% 1, 3-DG, 25%1, 2-DG and 20% TG) (4) is now commercially available. Natural edible oil contains 1, 2 DG and 1, 3-DG as minor components. 1, 2-DG is con verted to 1, 3-DG by aryl migration in edible oils (10) . 1, 2-DG is an intermediate of TG digestion in the intes tine. However, further studies on the health safety of DG oil (containing such a high level of DG, 80% in total) should be investigated. A genetically obese Wistar fatty rat with non-insulin dependent diabetes mellitus was produced by combin ing the insulin resistance of the Wistar Kyoto strain with the fa gene of the Zucker strain for obesity (11) . The male Wistar fatty rats are obese, hyperglycemic, hy perphagic, hyperinsulinemic, and hypertriglyceridemic. They also show impaired glucose tolerance and a glycemic response to exogenous insulin (11, 12) . However, the female rats are obese, hyperinsulinemic, and hypertriglyceridemic, but normoglycemic. In the present study, we have investigated the effects of dietary DG oil on glucose and lipid metabolism as compared to TG oil and those of increased free fatty acids on insulin resistance in the genetically obese type of female Wistar fatty rat.
MATERIALS AND METHODS
Materials. The insulin assay kit was obtained from Eiken Chemical Company (Tokyo, Japan). Most other reagents were obtained from Wako (Osaka, Japan) and from Sigma (St. Louis, MO, USA). For dietary fat, Nisshin salad oil (a mixture of rapeseed oil and soyean oil, Nisshin Oillo Co., Tokyo) was used as the TG oil, and Kao Econa (Kao Co., Tokyo) was used as the DG oil, The oral glucose tolerance test was done at 4wk of feeding experimental diets, 1 wk before the rats were sacrificed. Rats were given a 400g/L glucose solution (3g glucose/kg body weight) by stomach tube after being deprived of food for 20h. Blood was taken with a heparinized syringe from the tail vein.
Dot blot and Northern blot hybridization assays. Human insulin receptor cDNA (15) was a generous gift from Professor Y. Ebina (Institute for Enzyme Research , University of Tokushima, Japan). The genomic clone of rat rRNA was obtained from the Japanese Cancer Research Resources Bank (Mishima, Japan). A fragment of about 1 kb BamHI/EcoRI of this clone was isolated and used as a probe for 18 S rRNA. Total RNA was iso lated from liver and adipose tissues by acid guanidium thiocyanate-phenol-chloroform extraction (16 Northern blot analysis of RNA was performed as de scribed by Gonzales and Kasper (18) . Total RNA was de natured and electrophoresed on a 1.0% agarose gel containing 2.2 mol/L formaldehyde. The gel was blotted onto a nylon filter according to Thomas (19) . Details of prehybridization, hybridization, and autoradiography were as described previously (17) . The autoradiograms of the Northern blot analysis of insulin receptors were shown in our previous report (20) .
Analyses. Plasma glucose concentrations were de termined by the glucose-oxidase method (21) . Plasma insulin concentrations were measured by a two-anti body system radioimmunoassay according to the method of Morgan and Lazarow (22) . Plasma and liver TG concentrations were measured by the method of Fletcher (23) . The concentrations of plasma free fatty acids and total ketone bodies were measured by the methods of Kushiro and Fukui (24) and Harano et al . (25) , respectively.
Statistical analysis. Two-way ANOVA was followed by inspection of all differences between pairs of means using the least significant difference test (26) . Dif ferences were considered significant at p<0 .05.
RESULTS

Animal profiles
The final body weights, liver weights (g/100g bw) , and abdominal fat weights of obese rats and their lean littermates are shown in Table 1 . The body weights , liver weights, abdominal fat weights , and feed efficien cies were significantly larger in obese rats than in lean rats, but were not significantly different due to dietary fat.
Effects of dietary fat types on plasma glucose and insulin concentrations
The plasma glucose concentrations were significantly higher (p<0.05) in the portal vein and inferior vena cava of rats fed DG oil as compared to those fed TG oil (Fig. 1) . The plasma insulin concentrations in the portal vein were significantly higher (p<0.05) in lean rats fed DG oil than in those fed TG oil. The insulin concentra tions in both veins were markedly higher (p<0.001) in obese rats than in the lean rats. Effects of dietary fat types on plasma free fatty acid and ke tone body concentrations
The plasma free fatty acid concentrations of the por tal vein and inferior vena cava were higher (p<0.001) in the DG oil group than in the TG oil group of the obese and lean rats, particularly in the obese rats (Fig. 2) . The free fatty acid concentrations were higher (p<0.001) in the portal vein than in the inferior vena cava. The The plasma TG concentrations in the portal vein and inferior vena cava of both obese and lean rats were not significantly different in the DG and TG oil groups ( Table 2 ). The liver TG concentrations were also not sig nificantly different between the dietary fat types. The plasma and liver TG concentrations were markedly higher (p<0.001) in the obese rats than in the lean rats. Effects of dietary fat types on increments of plasma glucose and insulin concentrations in the glucose tolerance test
The increments of plasma glucose and insulin levels in response to an oral glucose load in a typical experi ment are shown in Fig. 3 . Comparable increments in the glucose and insulin values (0 to 120min after glu cose intubation) were calculated from the increment values (Table 3 ). The increments in glucose values were not significantly different due to dietary fat type in the lean rats. In the obese rats, however, the increments in glucose values were significantly elevated (p<0.05) by dietary DG oil as compared to TG oil. Consequently, the increments in glucose values were significantly higher in the obese rats fed DG as compared to the lean rats. and lean rats. The increments of insulin values were markedly higher (p<0.01) in obese rats fed either diet than in the lean rats. Thus, in the glucose tolerance test, dietary DG oil stimulated glucose intolerance as compared to TG oil in the obese rats.
Effects of dietary fat types on mRNA expressions of insulin receptors The insulin receptor mRNA expressions in liver and abdominal adipose tissues were not significantly differ ent between the dietary fat groups of the obese and lean rats (Fig. 4) . The insulin receptor expressions of the adi pose tissues were markedly lower (p<0.001) in the obese rats than in the lean rats, whereas the expres sions of liver were not different between the groups.
DISCUSSION
In the present study, in genetically obese Wistar fatty rats fed a synthetic diet containing 10% (by weight, 22.4% by calorie) DG oil for 5wk, the body weights and abdominal fat weights were not significantly different as compared to rats fed a diet containing TG oil. The plasma and liver TG concentrations were also not sig nificantly different between both oils. However, Murase et al. reported that, in obesity-prone C57BL/6J mice fed a diet containing 30% (by weight, 52.8% by calorie) DG oil for 5mo, body weight gain and visceral fat weight were reduced by 70% and 79%, respectively, as com pared to a TG oil-fed group (27) .
Moreover, their group also reported that, in healthy male humans, body weight, BMI, and waist circumfer-ence were decreased by the intake of only 10gld of DG oil (4.9% by calorie) for 16 wk as compared to controls fed TG oil (4). Total fat, visceral fat area, and subcuta neous fat area of the abdominal traverse images of com puted tomography were also reduced by dietary DG oil. In another report (1), the plasma TG levels and body fat ratio were significantly reduced in normal rats fed a 10% (by weight) DG oil diet for 3 and 4wk as compared to the TG oil diet. In our previous study of normal rats, however, significant effects of dietary DG oil on body weights, abdominal fat weights, and plasma TG levels were not observed in rats fed 10% (by weight, 22.4% by calories) DG oil for 1-12 wk (28). Although they found DG oil lipid-lowering effects on humans (4), rats (1), and obese mice (27), we could not find the DG oil effects in normal and obese rats. They did not provide a de scription of paired-feeding between the DG and TG oil groups. Since dietary energy and nutrient compositions greatly influence the lipid lowering effects, paired-feed ing is important in this kind of experiment. It is well known that polyunsaturated fatty acids (PUFA) suppress fatty acid synthesis and then TG levels. The DG and TG oils used in the present study contained 55% and 40% PUFA, respectively. The fatty acid compo sitions are described in Materials and Methods. Although the plasma and liver TG concentrations in creased with increasing dietary PUFA contents, the concentrations began leveling off (29) . Based on these results, the effects of the difference in PUFA contents of the oils on TG concentrations were suggested to be worth only slight consideration in the present experi ments. Incidentally, although the PUFA contents were higher in the DG oil diet than in the TG oil diet, lipid lowering effects were not found in the DG oil group. n the present study, the plasma free fatty acid con centrations were markedly elevated by dietary DG oil as compared to TG oil in both genotype rats, particularly in the obese. It was also reported that, after intragastric infusion of an emulsion containing DG oil, portal vein free fatty acids were markedly elevated as compared to TG oil (1) . In the glucose tolerance test, the obese rats fed DG oil showed an elevated glucose intolerance as compared to TG oil. Thus, it is suggested that dietary DG oil may induce insulin resistance due to the marked increase of plasma free fatty acid concentrations in the obese rats. Since the insulin receptor expressions of the Although plasma and liver TG concentrations were markedly high in the obese rats, the TG concentrations were not reduced by dietary DG oil, The body weights and abdominal fat weights were not reduced by dietary DG oil. Thus, the lipid-lowering effects of dietary DG oil on the TG concentrations and the abdominal fat weight, were not observed in both obese and lean rats in the present experiment. Moreover, glucose intolerance was observed in the obese rats fed DG oil. Further studies on the health safety of DG oil (containing such a high level of DG, 80% in total) should be investigated, particularly in the case of ingesting considerable amounts of DG oil as daily food for obese subjects.
